Evidence map›Paper›PMID 35652422›Full record

ArticleClinical transplantation2022

Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey.

Ben Sadeh, Sharon Ugolini, Omar Wever Pinzon, Evgenij V Potapov, Craig H Selzman, Feras Bader, Andreas O Zuckermann, Juan Esteban Gomez-Mesa, Kevin S Shah, Rami Alharethi and 8 more

Open access · greenAbstract read
In one paragraph

Article in Clinical transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors.Journal of the American College of Cardiology · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 10 countries.

Ben SadehDepartment of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel.ORCID 0000-0002-2836-7600
Sharon UgoliniDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Omar Wever PinzonDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Evgenij V PotapovDepartment of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
Craig H SelzmanDivision of Cardiothoracic Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Feras BaderHeart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates.
Andreas O ZuckermannDepartment of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Juan Esteban Gomez-MesaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, Colombia.ORCID 0000-0002-6635-6224
Kevin S ShahDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Rami AlharethiIntermountain Medical Center Heart Institute, Salt Lake City, Utah, USA.
Paola Morejon-BarraganHeart Failure and Transplantation Unit, Cardiac Critical Care Unit, Clinica Guayaquil, Guayaquil, Ecuador.
Thomas HanffDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Livia A GoldraichHeart Transplantation Unit, Cardiology Department, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Marta FarreroHeart Failure Unit, Cardiology, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0000-0002-2404-8821
Peter S MacDonaldHeart Failure and Transplant Unit, Cardiology Department, St Vincent's Hospital, Sydney, Australia.
Stavros DrakosDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Mandeep R MehraCenter for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
Josef StehlikDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-7362-0513
University of Utah · USAbu Dhabi Health Services · AEBrigham and Women's Hospital · USDeutsches Herzzentrum der Charité · DEFundación Valle del Lili · COHospital Clínic de Barcelona · ESIntermountain Medical Center · USMedical University of Vienna · ATSt Vincent's Hospital Melbourne · AUTel Aviv University · ILUniversidade Federal do Rio Grande do Sul · BRUniversity of Guayaquil · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA growing proportion of transplant donors and recipients have a history of COVID-19 infection. This study sought to characterize clinical practice after recipient or donor COVID-19 infection.

methodsAn online survey was distributed to heart transplant clinicians through a professional society message board and social media. Responses were collected between September 29 and November 5, 2021.

resultsThere were 222 health care professionals (68% transplant cardiologists, 22% transplant surgeons, 10% other) across diverse geographic regions who completed the survey. While there was significant variation in donor acceptance, as it relates to past and current COVID-19 infection, the respondents were fairly cautious: 28% would not typically accept a donor with a history of COVID-19 regardless of the infection course and > 80% would not accept donors who had evidence of myocardial dysfunction during past COVID-19 infection, or who died of COVID-19 or its complications. The timing of candidate reactivation on the waiting list after COVID-19 infection also varied and often diverged from scenarios addressed by social guidelines. Eighty-one percent of the respondents felt COVID-19 vaccine should be mandatory before transplant, but this rate varied by geographic region.

conclusionOur results reflect evolving experience of the heart transplant field at a time of lack of high-quality evidence. In the absence of longer-term outcome data for donors and transplant candidates with history of COVID-19 infection, clinicians remain cautious; however, this approach will likely need to be refined as an increasing proportion of the population will continue to be infected with COVID-19.

Indexed as

COVID-19Heart TransplantationCOVID-19 VaccinesHumansSurveys and QuestionnairesTissue DonorsTransplant RecipientsCOVID-19 VaccinesCOVID-19COVID vaccinationheart transplantationISHLT

Identifiers

PMID35652422
PMCPMC9347846
OpenAlexW4281887612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.